Aromatase Inhibitors May Raise Heart Risks

Postmenopausal women with early breast cancer who take newer hormone drugs known as aromatase inhibitors are 26% more likely to develop heart disease than those who take the old standby tamoxifen, researchers report.
Read the original post:
Aromatase Inhibitors May Raise Heart Risks

Posted by
on December 9, 2010. Filed under
Health,
News.
You can follow any responses to this entry through the
RSS 2.0.
You can leave a response or trackback to this entry